Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4039-4045

  Longenecker, Chris T ^a   Jiang, Ying ^b   Yun, Chun Ho ^c   Debanne, Sara ^b   Funderburg, Nicholas T ^d   Lederman, Michael M ^d   Storer, Norma ^d   Labbato, Danielle E ^d   Bezerra, Hiram G ^a   McComsey, Grace A ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adipose tissue; Atherosclerosis; HIV; Inflammation; Macrophages

Indexed keywords

ABACAVIR; C REACTIVE PROTEIN; CD14 ANTIGEN; CD163 ANTIGEN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR I; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS RNA; ANTIRETROVIRUS AGENT;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; AGE; ANTIVIRAL THERAPY; ARTICLE; BODY FAT; BODY MASS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; EPICARDIAL ADIPOSE TISSUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; INFLAMMATION; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SEX; T LYMPHOCYTE ACTIVATION; THORACIC PERIAORTIC ADIPOSE TISSUE; WAIST HIP RATIO; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HIV INFECTIONS; MIDDLE AGED; PATHOLOGY; PERICARDIUM; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VASCULAR CALCIFICATION;

ADIPOSE TISSUE; ADULT; ANTI-RETROVIRAL AGENTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERICARDIUM; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84886290126     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.059     Document Type: Article

References (38)

1. G.A. McComsey, D. Kitch, and P.E. Sax Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s Clin Infect Dis 53 2 Jul. 15 2011 185 196
2. M. Tungsiripat, and G. McComsey Pathogenesis and management of lipoatrophy Curr HIV/AIDS Rep 5 2 May 2008 55 63
3. G. McComsey, A. Rightmire, V. Wirtz, R. Yang, M. Mathew, and D. McGrath Changes in body composition with ritonavir-boosted and unboosted atazanavir treatment in combination with lamivudine and stavudine: a 96-week randomized, controlled study Clin Infect Dis 48 9 May 1 2009 1323 1326
4. K. Samaras, S.K. Gan, P.W. Peake, A. Carr, and L.V. Campbell Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection Obesity (Silver Spring) 17 1 Jan. 2009 53 59
5. J.E. Lake, D. Wohl, and R. Scherzer Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study AIDS Care 23 8 Aug. 2011 929 938
6. C. Grunfeld, M. Saag, and J. Cofrancesco Jr. Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy AIDS 24 11 Jul. 17 2010 1717 1726
7. A.R. Baker, N.F. Silva, and D.W. Quinn Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease Cardiovasc Diabetol 5 2006 1
8. A.R. Baker, A.L. Harte, and N. Howell Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease J Clin Endocrinol Metab 94 1 Jan. 2009 261 267
9. T. Mazurek, L. Zhang, and A. Zalewski Human epicardial adipose tissue is a source of inflammatory mediators Circulation 108 20 Nov. 18 2003 2460 2466
10. K.A. Campbell, M.J. Lipinski, A.C. Doran, M.D. Skaflen, V. Fuster, and C.A. McNamara Lymphocytes and the adventitial immune response in atherosclerosis Circ Res 110 6 Mar. 16 2012 889 900
11. J. Lo, S. Abbara, J.A. Rocha-Filho, L. Shturman, J. Wei, and S.K. Grinspoon Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters AIDS 24 13 Aug. 24 2010 2127 2130
12. G. Guaraldi, R. Scaglioni, and S. Zona Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients AIDS 25 9 Jun. 1 2011 1199 1205
13. O. Gabriella, G. Giovanni, and Z. Stefano Ectopic fat is linked to prior cardiovascular events in men with HIV J Acquir Immune Defic Syndr 59 5 Apr. 15 2012 494 497
14. S.J. Lehman, J.M. Massaro, C.L. Schlett, C.J. O'Donnell, U. Hoffmann, and C.S. Fox Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study Atherosclerosis 210 2 Jun. 2010 656 661
15. C.S. Fox, J.M. Massaro, and C.L. Schlett Periaortic fat deposition is associated with peripheral arterial disease: the Framingham Heart Study Circ Cardiovasc Imaging 3 5 Sep. 2010 515 519
16. S. Subramanian, A. Tawakol, and T.H. Burdo Arterial inflammation in patients with HIV JAMA 308 4 Jul. 25 2012 379 386
17. C.H. Yun, T.Y. Lin, and Y.J. Wu Pericardial and thoracic peri-aortic adipose tissues contribute to systemic inflammation and calcified coronary atherosclerosis independent of body fat composition, anthropometric measures and traditional cardiovascular risks Eur J Radiol 81 4 Apr. 2012 749 756
18. J.H. Stein, C.E. Korcarz, and R.T. Hurst Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine J Am Soc Echocardiogr 21 2 Feb. 2008 93 111 (quiz 89-90)
19. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 3 Jan. 27 2004 433 438
20. G. Iacobellis, A.M. Pellicelli, and B. Grisorio Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat Obesity (Silver Spring) 16 1 Jan. 2008 179 183
21. R. Nair, A. Abdool-Carrim, R. Chetty, and J. Robbs Arterial aneurysms in patients infected with human immunodeficiency virus: a distinct clinicopathology entity? J Vasc Surg 29 4 Apr. 1999 600 607
22. M.D. Tilson 3rd, and L. Withers Arterial aneurysms in HIV patients: molecular mimicry versus direct infection? Ann N Y Acad Sci 1085 Nov. 2006 387 391
23. M. Floris-Moore, Z.A. Fayad, and J.W. Berman Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging AIDS 23 8 May 15 2009 941 949
24. K. Singh, K.H. Bonaa, B.K. Jacobsen, L. Bjork, and S. Solberg Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromso Study Am J Epidemiol 154 3 Aug. 1 2001 236 244
25. J.E. Ho, R. Scherzer, and F.M. Hecht The association of CD4 + T-cell counts and cardiovascular risk in treated HIV disease AIDS 26 9 Jun. 1 2012 1115 1120
26. K.A. Lichtenstein, C. Armon, and K. Buchacz Low CD4 + T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study Clin Infect Dis 51 4 Aug. 15 2010 435 447
27. V.A. Triant, S. Regan, H. Lee, P.E. Sax, J.B. Meigs, and S.K. Grinspoon Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system J Acquir Immune Defic Syndr 55 5 Dec. 15 2010 615 619
28. E. Seminari, C. Tinelli, and L. Minoli Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients Antivir Ther 7 3 Sep. 2002 175 180
29. H.E. Bays Adiposopathy is "sick fat" a cardiovascular disease? J Am Coll Cardiol 57 25 Jun. 21 2011 2461 2473
30. M.G. Farb, S. Bigornia, and M. Mott Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity J Am Coll Cardiol 58 3 Jul. 12 2011 232 237
31. K.M. Pou, J.M. Massaro, and U. Hoffmann Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 11 Sep. 11 2007 1234 1241
32. T.M. Tadros, J.M. Massaro, and G.A. Rosito Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study Obesity (Silver Spring) 18 5 May 2010 1039 1045
33. C.M. Apovian, S. Bigornia, and M. Mott Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects Arterioscler Thromb Vasc Biol 28 9 Sep. 2008 1654 1659
34. Y. Hirata, M. Tabata, and H. Kurobe Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue J Am Coll Cardiol 58 3 Jul. 12 2011 248 255
35. H. Wu, S. Ghosh, and X.D. Perrard T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity Circulation 115 8 Feb. 27 2007 1029 1038
36. D. Sporrer, M. Weber, and J. Wanninger Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity Eur J Clin Invest 39 8 Aug. 2009 671 679
37. M.V. Zanni, T.H. Burdo, H. Makimura, K.C. Williams, and S.K. Grinspoon Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects Clin Endocrinol (Oxf) 77 3 Sep 2012 385 390
38. T.H. Burdo, J. Lo, and S. Abbara Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients J Infect Dis 204 8 Oct 15 2011 1227 1236